Status:

UNKNOWN

Electronic Capture of Adherence Barriers for HIV Care

Lead Sponsor:

McGill University Health Centre/Research Institute of the McGill University Health Centre

Collaborating Sponsors:

CIHR Canadian HIV Trials Network

Conditions:

HIV Infections

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Adherence to antiretroviral therapy (ART) remains problematic. Our team has thus developed a new patient-reported measure of barriers to ART adherence (the I-Score) which will be completed by HIV pati...

Detailed Description

Background: Adherence to antiretroviral therapy (ART) remains problematic. Regular monitoring of its barriers is clinically recommended, however, patient-provider communication around adherence is oft...

Eligibility Criteria

Inclusion

  • be aged 18 years or older
  • be diagnosed with HIV-1 infection
  • be treated with a combination antiretroviral therapy (composed of 2 to 3 different drugs)
  • be treated for HIV at the Chronic Viral Illness Service of the McGill University Health Centre
  • be able to speak and understand either French or English
  • possess a smartphone
  • be willing to download the smartphone app

Exclusion

  • are participating in a clinical trial at the time of enrollment in this study
  • have a cognitive impairment or medical instability that prevents them from participating in the interview
  • have insufficient mastery of French or English to participate in the interview and complete the questionnaires
  • have insufficient ability to use the app with the technical support provided
  • are co-infected with hepatitis C and are being treated for it or have completed treatment 3 months or less ago
  • are co-infected with hepatitis B and are either not treated for it or are being treated for it with a medication other than their anti-HIV medication

Key Trial Info

Start Date :

January 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2022

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT04702412

Start Date

January 1 2021

End Date

January 1 2022

Last Update

January 8 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Research Institute of the McGill University Health Centre

Montreal, Quebec, Canada, H4A3T2